Protopic (tacrolimus) - Important Safety Information from Astellas Pharma Europe as approved by the Irish Medicines Board
17 May 2012
Important Safety Information communication from Astellas Pharma Europe on recommendations for appropriate use of Protopic (tacrolimus) (0.03% and 0.1%) ointment to minimise risks.
Important Safety Information - Protopic